H. B. Fuller (NYSE:FUL – Get Free Report) was upgraded by equities research analysts at Vertical Research from a “hold” rating to a “strong-buy” rating in a report issued on Friday,Zacks.com reports.
A number of other research firms have also weighed in on FUL. Citigroup lowered their price target on shares of H. B. Fuller from $76.00 to $67.00 and set a “buy” rating for the company in a report on Thursday, March 19th. Weiss Ratings reiterated a “hold (c)” rating on shares of H. B. Fuller in a report on Monday, December 29th. UBS Group decreased their price objective on shares of H. B. Fuller from $66.00 to $63.00 and set a “neutral” rating for the company in a research report on Friday. Wall Street Zen downgraded H. B. Fuller from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of H. B. Fuller in a research report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $64.75.
Read Our Latest Stock Analysis on FUL
H. B. Fuller Stock Up 3.6%
H. B. Fuller (NYSE:FUL – Get Free Report) last issued its quarterly earnings data on Wednesday, March 25th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.01. The company had revenue of $770.84 million during the quarter, compared to the consensus estimate of $787.77 million. H. B. Fuller had a net margin of 4.62% and a return on equity of 11.84%. H. B. Fuller’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter last year, the company earned $0.54 earnings per share. As a group, sell-side analysts predict that H. B. Fuller will post 4.07 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the stock. Strs Ohio bought a new stake in shares of H. B. Fuller in the 1st quarter worth about $101,000. JPMorgan Chase & Co. grew its stake in H. B. Fuller by 16.2% in the second quarter. JPMorgan Chase & Co. now owns 612,048 shares of the specialty chemicals company’s stock worth $36,815,000 after purchasing an additional 85,469 shares in the last quarter. Legal & General Group Plc grew its stake in H. B. Fuller by 0.4% in the second quarter. Legal & General Group Plc now owns 147,799 shares of the specialty chemicals company’s stock worth $8,890,000 after purchasing an additional 565 shares in the last quarter. Rhumbline Advisers increased its holdings in H. B. Fuller by 4.7% in the second quarter. Rhumbline Advisers now owns 185,154 shares of the specialty chemicals company’s stock valued at $11,137,000 after buying an additional 8,282 shares during the last quarter. Finally, Coldstream Capital Management Inc. increased its holdings in H. B. Fuller by 712.2% in the second quarter. Coldstream Capital Management Inc. now owns 6,254 shares of the specialty chemicals company’s stock valued at $376,000 after buying an additional 5,484 shares during the last quarter. 95.93% of the stock is owned by institutional investors and hedge funds.
Key Stories Impacting H. B. Fuller
Here are the key news stories impacting H. B. Fuller this week:
- Positive Sentiment: Company announced a global price hike of at least 10% starting April to address petrochemical supply constraints and rising input costs — a measure likely to help margins and cash flow. Article Title
- Positive Sentiment: Management issued FY guidance of $4.55–$4.90 in EPS and mid-single-digit revenue growth, signaling confidence that price actions and cost management will offset supply volatility. Article Title
- Positive Sentiment: Q1 EPS of $0.57 beat consensus ($0.56), and management reiterated improved profitability drivers; several outlets characterize the quarter as a solid start despite top-line pressure. Article Title
- Neutral Sentiment: Full earnings call transcript, slide deck and presentations are available for investors to review detailed segment results and management commentary. Earnings Call Transcript
- Negative Sentiment: Revenue missed estimates ($770.8M reported vs. ~$787.8M consensus) and was down 2.3% year-over-year, a near-term headwind for growth expectations. Article Title
- Negative Sentiment: UBS lowered its price target from $66 to $63 and moved to a neutral rating, which could cap upside momentum and signal analyst caution. Article Title
- Negative Sentiment: Some analysts expressed reduced optimism after the quarter, highlighting mixed signals (beat on EPS vs. weaker revenue and supply risks) that may keep multiple compression or volatility in place. Article Title
H. B. Fuller Company Profile
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Further Reading
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
